Pharma Market Access Insights - from Petauri Evidence

64 Episodo

1. Market access in the German speaking markets

   Publicado: 29/8/2023
2. The role of nursing in driving digital change in the NHS

   Publicado: 26/7/2023
3. Market access for digital therapies and digital medicines

   Publicado: 19/7/2023
4. A global market access journey in cannabinoid pharmaceuticals

   Publicado: 17/6/2023
5. Primary Care and ICBs – what is the next step in the integration journey?

   Publicado: 15/5/2023
6. Data-led transformation in the NHS - partnering to optimise patient care

   Publicado: 31/3/2023
7. Innovating for better health – research, collaboration and innovation in the NHS

   Publicado: 7/3/2023
8. Healthcare, economics and society – unlocking NHS collaboration

   Publicado: 30/1/2023
9. Specialised Commissioning in the NHS – What do you need to know now

   Publicado: 13/1/2023
10. Why are we waiting? - Pressures facing the NHS and how to deliver change

    Publicado: 29/11/2022
11. Priority setting in primary care - NHS insights

    Publicado: 18/10/2022
12. Integrated Care Systems go live in the NHS - reflections after 3 weeks

    Publicado: 9/8/2022
13. Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role

    Publicado: 1/8/2022
14. Transforming systems and care pathways for an integrated NHS

    Publicado: 21/6/2022
15. Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers

    Publicado: 4/5/2022
16. Population to Person: How will the NHS translate population health management into impactful, person-centred service change?

    Publicado: 15/3/2022
17. Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?

    Publicado: 11/2/2022
18. The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

    Publicado: 17/1/2022
19. Optimising the NHS – How will medicines be valued in integrated systems?

    Publicado: 21/12/2021
20. Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe

    Publicado: 29/11/2021